Andrea J Sharma1,2, Nicole D Ford1,3, Joanna E Bulkley4, Lindsay M Jenkins4, Kimberly K Vesco4,5, Anne M Williams1,3. 1. Division of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2. US Public Health Service Commissioned Corps, Atlanta, GA, USA. 3. McKing Consulting Corporation, Fairfax, VA, USA. 4. Kaiser Permanente Center for Health Research, Portland, OR, USA. 5. Department of Obstetrics & Gynecology, Kaiser Permanente Northwest, Portland, OR, USA.
Abstract
BACKGROUND: In the United States, the prevalence of anemia, iron deficiency (ID), and iron-deficiency anemia (IDA) during pregnancy remains largely unknown as data at the national or state level are limited or nonexistent, respectively. OBJECTIVES: In an effort to identify opportunities to improve maternal health surveillance, we assessed the feasibility of anemia, ID, and IDA surveillance among first-trimester pregnancies using electronic health records (EHRs). METHODS: We identified pregnancies among Kaiser Permanente Northwest members aged ≥18 y during 2005-2016 with first-trimester prenatal care (n = 41,991). Earliest laboratory test results for hemoglobin or hematocrit and ferritin were selected. We describe the proportion of pregnancies screened for and the prevalence of anemia, ID, and IDA; the concordance of anemia status by hemoglobin compared with hematocrit; and the proportion of pregnancies with laboratory-confirmed anemia that also had an International Classification of Diseases diagnostic code related to anemia. RESULTS: Identified pregnancies included women who were 73.1% non-Hispanic (NH) white, 11.5% Hispanic, 8.5% NH Asian/Pacific Islander, and 2.9% NH black. Hemoglobin and hematocrit results were available for 92.7% (n = 38,923) pregnancies. Anemia prevalence was 2.7% (n = 1045) based on hemoglobin <11.0 g/dL or hematocrit <33%; 45.2% of anemia cases had both low hemoglobin and low hematocrit. Among pregnancies with anemia, 18.9% (n = 197) had a ferritin result; of those, 48.2% had ID (ferritin <15 μg/L). In pregnancies without anemia, 3.4% (n = 1275) had a ferritin result; of those, 23.5% had ID. Based on 1472 pregnancies with both anemia and ID assessed, prevalence of ID and IDA was 26.8% and 6.5%, respectively; estimates likely represent selective screening. CONCLUSIONS: EHR data have potential to monitor anemia prevalence and trends in health systems where prenatal anemia screening is nearly universal. However, if iron assessment is not routine, then representative estimates of ID or IDA are unattainable. Published by Oxford University Press on behalf of the American Society for Nutrition 2021.
BACKGROUND: In the United States, the prevalence of anemia, iron deficiency (ID), and iron-deficiency anemia (IDA) during pregnancy remains largely unknown as data at the national or state level are limited or nonexistent, respectively. OBJECTIVES: In an effort to identify opportunities to improve maternal health surveillance, we assessed the feasibility of anemia, ID, and IDA surveillance among first-trimester pregnancies using electronic health records (EHRs). METHODS: We identified pregnancies among Kaiser Permanente Northwest members aged ≥18 y during 2005-2016 with first-trimester prenatal care (n = 41,991). Earliest laboratory test results for hemoglobin or hematocrit and ferritin were selected. We describe the proportion of pregnancies screened for and the prevalence of anemia, ID, and IDA; the concordance of anemia status by hemoglobin compared with hematocrit; and the proportion of pregnancies with laboratory-confirmed anemia that also had an International Classification of Diseases diagnostic code related to anemia. RESULTS: Identified pregnancies included women who were 73.1% non-Hispanic (NH) white, 11.5% Hispanic, 8.5% NH Asian/Pacific Islander, and 2.9% NH black. Hemoglobin and hematocrit results were available for 92.7% (n = 38,923) pregnancies. Anemia prevalence was 2.7% (n = 1045) based on hemoglobin <11.0 g/dL or hematocrit <33%; 45.2% of anemia cases had both low hemoglobin and low hematocrit. Among pregnancies with anemia, 18.9% (n = 197) had a ferritin result; of those, 48.2% had ID (ferritin <15 μg/L). In pregnancies without anemia, 3.4% (n = 1275) had a ferritin result; of those, 23.5% had ID. Based on 1472 pregnancies with both anemia and ID assessed, prevalence of ID and IDA was 26.8% and 6.5%, respectively; estimates likely represent selective screening. CONCLUSIONS: EHR data have potential to monitor anemia prevalence and trends in health systems where prenatal anemia screening is nearly universal. However, if iron assessment is not routine, then representative estimates of ID or IDA are unattainable. Published by Oxford University Press on behalf of the American Society for Nutrition 2021.
Entities:
Keywords:
anemia; iron deficiency; iron deficiency anemia; pregnancy; surveillance
Authors: Fernanda C G Polubriaginof; Patrick Ryan; Hojjat Salmasian; Andrea Wells Shapiro; Adler Perotte; Monika M Safford; George Hripcsak; Shaun Smith; Nicholas P Tatonetti; David K Vawdrey Journal: J Am Med Inform Assoc Date: 2019-08-01 Impact factor: 4.497
Authors: Zuguo Mei; Mary E Cogswell; Anne C Looker; Christine M Pfeiffer; Sarah E Cusick; David A Lacher; Laurence M Grummer-Strawn Journal: Am J Clin Nutr Date: 2011-03-23 Impact factor: 7.045
Authors: Jahnavi Daru; Katherine Colman; Simon J Stanworth; Barbara De La Salle; Erica M Wood; Sant-Rayn Pasricha Journal: Am J Clin Nutr Date: 2017-10-25 Impact factor: 7.045
Authors: A J Wilcox; C R Weinberg; J F O'Connor; D D Baird; J P Schlatterer; R E Canfield; E G Armstrong; B C Nisula Journal: N Engl J Med Date: 1988-07-28 Impact factor: 91.245
Authors: Zuguo Mei; Hongtian Li; Mary K Serdula; Rafael C Flores-Ayala; Linlin Wang; Jian-Meng Liu; Laurence M Grummer-Strawn Journal: Am J Hum Biol Date: 2016-02-11 Impact factor: 2.947
Authors: Sorrel Ml Namaste; Fabian Rohner; Jin Huang; Nivedita L Bhushan; Rafael Flores-Ayala; Roland Kupka; Zuguo Mei; Rahul Rawat; Anne M Williams; Daniel J Raiten; Christine A Northrop-Clewes; Parminder S Suchdev Journal: Am J Clin Nutr Date: 2017-06-14 Impact factor: 7.045
Authors: Gretchen A Stevens; Mariel M Finucane; Luz Maria De-Regil; Christopher J Paciorek; Seth R Flaxman; Francesco Branca; Juan Pablo Peña-Rosas; Zulfiqar A Bhutta; Majid Ezzati Journal: Lancet Glob Health Date: 2013-06-25 Impact factor: 26.763